{"id":160077,"date":"2024-02-16T14:41:12","date_gmt":"2024-02-16T05:41:12","guid":{"rendered":"https:\/\/www.fukuoka-now.com\/?post_type=news&#038;p=160077&#038;lang=en"},"modified":"2024-02-16T14:41:12","modified_gmt":"2024-02-16T05:41:12","slug":"kurume-based-venture-files-for-bankruptcy-amid-covid-19-drug-research","status":"publish","type":"news","link":"https:\/\/www.fukuoka-now.com\/en\/news\/kurume-based-venture-files-for-bankruptcy-amid-covid-19-drug-research\/","title":{"rendered":"Kurume-Based Venture Files for Bankruptcy Amid COVID-19 Drug Research"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">A venture company in Kurume City, which was engaged in joint research and development of a COVID-19 treatment with Fukuoka Prefecture, has filed for bankruptcy. The company, Bonac, established in 2010 and focused on researching and developing nucleic acid medicines, embarked on a project with the prefecture in 2020, which also received backing from the Japan Agency for Medical Research and Development. Despite securing a grant of 30 million yen from the prefecture and an anticipated 5 billion yen in support over three and a half years, the project was unable to demonstrate the drug&#8217;s effectiveness and was terminated. The company, which failed to produce marketable medical products from its other research endeavors, faced depleted research funds and deteriorating performance, leading to a debt of approximately 1.5 billion yen. Bonac&#8217;s bankruptcy application was filed on February 9, with the Fukuoka District Court in Kurume expected to initiate bankruptcy proceedings. <\/span><b>Source: <\/b><a href=\"https:\/\/www3.nhk.or.jp\/fukuoka-news\/20240215\/5010023431.html\" rel=\"noopener\" target=\"_blank\"><span style=\"font-weight: 400;\">NHK<\/span><\/a><\/p>\n<p><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" src=\"https:\/\/i0.wp.com\/www.fukuoka-now.com\/wp-content\/uploads\/2024\/02\/fnn_medicine-unsplash-feb-2024_cl.jpg?resize=1400%2C979&#038;ssl=1\" alt=\"Kurume-Based Venture Files for Bankruptcy Amid COVID-19 Drug Research\" width=\"1400\" height=\"979\" class=\"alignnone size-full wp-image-160085\" srcset=\"https:\/\/i0.wp.com\/www.fukuoka-now.com\/wp-content\/uploads\/2024\/02\/fnn_medicine-unsplash-feb-2024_cl.jpg?w=1400&amp;ssl=1 1400w, https:\/\/i0.wp.com\/www.fukuoka-now.com\/wp-content\/uploads\/2024\/02\/fnn_medicine-unsplash-feb-2024_cl.jpg?resize=300%2C210&amp;ssl=1 300w, https:\/\/i0.wp.com\/www.fukuoka-now.com\/wp-content\/uploads\/2024\/02\/fnn_medicine-unsplash-feb-2024_cl.jpg?resize=1024%2C716&amp;ssl=1 1024w, https:\/\/i0.wp.com\/www.fukuoka-now.com\/wp-content\/uploads\/2024\/02\/fnn_medicine-unsplash-feb-2024_cl.jpg?resize=768%2C537&amp;ssl=1 768w\" sizes=\"auto, (max-width: 1000px) 100vw, 1000px\" \/>Photo by Christine Sandu on Unsplash<\/p>\n<p><span style=\"font-weight: 400;\">Stay informed with the latest Fukuoka &amp; Kyushu news and events in English. Sign up for our <\/span><a href=\"https:\/\/www.fukuoka-now.com\/en\/mailmagazine\/\"><span style=\"font-weight: 400;\">free weekly newsletter <\/span><\/a><span style=\"font-weight: 400;\">today and never miss a beat. Opt out anytime, your privacy is our priority. Get the inside scoop with <\/span><a href=\"https:\/\/www.fukuoka-now.com\/en\/mailmagazine\/\"><span style=\"font-weight: 400;\">The Now<\/span><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Summaries based on public content, errors may occur during translation. Images credited independently. Send feedback using <\/span><a href=\"https:\/\/www.fukuoka-now.com\/en\/contact\/\"><span style=\"font-weight: 400;\">this <\/span><b>form<\/b><span style=\"font-weight: 400;\">.<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A venture company in Kurume City, which was engaged in joint research and development of a COVID-19 treatment with Fukuoka Prefecture, has filed for bankruptcy. The company, Bonac&#8230;<\/p>\n","protected":false},"author":29305,"featured_media":160090,"comment_status":"closed","ping_status":"closed","template":"","tags":[],"class_list":["post-160077","news","type-news","status-publish","has-post-thumbnail","hentry","location-kurume","news-category-business","en-US"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/news\/160077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/users\/29305"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/comments?post=160077"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/media\/160090"}],"wp:attachment":[{"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/media?parent=160077"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fukuoka-now.com\/wp-json\/wp\/v2\/tags?post=160077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}